Outstanding Recoveries
- Home
- Outstanding Recoveries
Verdicts & Settlements
Since Milberg’s founding in 1965, the firm has recovered more than $50 billion for our clients while prompting meaningful changes in corporate governance.
Filter By
Select Practice Area
-
See More$100 Million Settlement – American Express Financial Advisors Securities Litigation
In re American Express Financial Advisors Securities Litigation, No. 04-1773 (S.D.N.Y.)This case involved allegations that American Express Financial Advisors violated securities laws by representing to class members that the company would provide tailored financial advice when the company actually provided “canned” financial plans and advice designed to steer clients into American Express and certain non-proprietary mutual funds. The case settled for $100 million and required the company to adopt various remedial measures. -
See More$106 Million Settlement – Daedalus, LLC v. City of Charlotte
Daedalus, LLC v. City of Charlotte, Mecklenburg Co. File No. 18-CVS-21073 (NC)$106 million class settlement on behalf of developers and home builders for illegally charged water and sewer capacity fees. -
See More$100 Million Settlement – Chase Bank USA, N.A. “Check Loan” Contract Litigation
In re Chase Bank USA, N.A. “Check Loan” Contract Litig., No. 09-2032 (N.D. Cal.)Milberg served on the Executive Committee representing the class in this action against JP Morgan Chase & Co. The complaint alleged that Chase improperly increased by 150% the minimum monthly payment required for customers who entered into balance transfer loans with “fixed” interest rates that were guaranteed to remain so for the “life of the loan.” Milberg and its Co-Counsel achieved a $100 million settlement for the class. -
See More$330+ Million Settlement – Rite Aid Corp. Securities Litigation
In re Rite Aid Corp. Securities Litigation, No. 99-1349 (E.D. Pa.)Milberg served as Co-Lead Counsel in this case, in which plaintiffs asserted federal securities fraud claims based on Rite Aid’s alleged failure to disclose material problems with its store expansion and modernization program resulting in artificially inflated earnings. The court-approved settlements totaled over $330 million. -
See More$3.4 Billion Settlement – Avandia Marketing, Sales Practices, and Products Liability Litigation
In re Avandia Marketing, Sales Practices, and Products Liability Litigation, MDL 1871 (U.S. District Court for the Eastern District of Pennsylvania)Milberg attorneys were appointed to the Plaintiffs Steering Committee and served on the Discovery and Media Sub-Committees on behalf of thousands of patients who took the Type 2 diabetes drug Avandia, alleging the manufacturer failed to disclose the known and increased risk of heart attack and cardiac death. GlaxoSmithKline set aside $3.4 billion in 2011 to settle lawsuits.
